Type

All patients

(n = 93)

IDH

Control

Antihypertensive treatment

59 (63.4%)

17 (81%)

42 (58.3%)

ICE

37 (39.8%)

10 (55.6%)

27 (55.1%)

AAR

7 (11.3%)

3 (17.6%)

4 (8.9%)

ICC

41 (66.1%)

13 (76.5%)

28 (62.2%)

Beta-blockers

16 (25.8%)

5 (29.4%)

11 (24.4%)

Number of molecules (mean)

1.98 ± 1.06

2.06 ± 1.25

1.95 ± 0.99